Share-based Payment Arrangement, Expense of BIO-PATH HOLDINGS, INC. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIO-PATH HOLDINGS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • BIO-PATH HOLDINGS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $27,000, a 73% decline year-over-year.
  • BIO-PATH HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $600,000, a 14% decline from 2023.
  • BIO-PATH HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $700,000, a 22% decline from 2022.
  • BIO-PATH HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $900,000, a 12% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIO-PATH HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $27,000 -$73,000 -73% 01 Jul 2025 30 Sep 2025 10-Q 13 Jan 2026 2025 Q3
Q3 2024 $100,000 01 Jul 2024 30 Sep 2024 10-Q 13 Jan 2026 2025 Q3
Q2 2023 $900,000 $200,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $900,000 $200,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $900,000 $300,000 +$100,000 +50% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $800,000 $200,000 -$100,000 -33% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $900,000 $200,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $900,000 $200,000 +$100,000 +100% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $800,000 $200,000 $0 0% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $800,000 $300,000 +$200,000 +200% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $600,000 $200,000 +$100,000 +100% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $500,000 $100,000 -$100,000 -50% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $600,000 $200,000 +$100,000 +100% 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $500,000 $100,000 -$100,000 -50% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $600,000 $100,000 -$100,000 -50% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $700,000 $200,000 $0 0% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $700,000 $100,000 -$100,000 -50% 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $800,000 $200,000 $0 0% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $800,000 $200,000 +$100,000 +100% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $700,000 $200,000 +$100,000 +100% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $600,000 $200,000 +$100,000 +100% 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $500,000 $200,000 $0 0% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $500,000 $100,000 -$200,000 -67% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $700,000 $100,000 -$100,000 -50% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $800,000 $100,000 -$200,000 -67% 01 Oct 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
Q3 2017 $1,000,000 $200,000 $0 0% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $1,000,000 $300,000 +$100,000 +50% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $900,000 $200,000 +$100,000 +100% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $800,000 $300,000 +$200,000 +200% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $600,000 $200,000 +$100,000 +100% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $500,000 $200,000 +$100,000 +100% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $400,000 $100,000 $0 0% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $400,000 $100,000 +$16,861 +20% 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 $383,139 $100,000 -$18,047 -15% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $401,186 $100,000 -$22,793 -19% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $423,979 $100,000 +$13,722 +16% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $83,139 01 Dec 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
Q3 2014 $118,047 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $122,793 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $86,278 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1

BIO-PATH HOLDINGS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $600,000 -$100,000 -14% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $700,000 -$200,000 -22% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $900,000 +$100,000 +12% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $800,000 +$200,000 +33% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $600,000 -$100,000 -14% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $700,000 +$100,000 +17% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $600,000 -$200,000 -25% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $800,000 $0 0% 01 Jan 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
2016 $800,000 +$400,000 +100% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $400,000 $0 0% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
2014 $400,000 -$304,480 -43% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $704,480 +$641,095 +1011% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $63,385 01 Jan 2012 31 Dec 2012 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.